|
|
||||||||

* Muscle Biology Laboratory, School of Kinesiology, University of Illinois, Chicago, Illinois 60608; and
Departments of Geriatrics and Physiology and Biophysics, Reynolds Center on Aging, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
To whom requests for reprints should be addressed at 1 Department of Geriatrics, UAMS, 4301 West Markham #807, Little Rock, AR 72205. E-mail: dupontesthere@uams.edu
Duchenne muscular dystrophy is a musculoskeletal disease caused by mutations in the dystrophin gene. The purpose of this study was to use the mouse model of muscular dystrophy (mdx) to determine if the progression of the dystrophic phenotype in the diaphragm (costal) versus limb skeletal muscle (tibialis anterior) is associated with specific changes in extracellular regulated kinase (ERK1/2), p70 S6 kinase (p70S6k), or p38 signaling pathways. The studies detected that consistent with an earlier dystrophic phenotype, phosphorylation of p70S6k is elevated by 40% in the diaphragm with no change in limb muscle. In addition, phosphorylation of p38 kinase was decreased by 33% in the mdx diaphragm muscle. Levels of ERK1/2 as well as phosphorylation states were elevated in the diaphragm and limb muscle of mdx mice compared with age-matched control muscles. These results indicate that distinct signaling pathways are differentially activated in skeletal muscle of mdx mice. The specificity of these responses, particularly in the diaphragm, provides insight for potential targets for blunting the progression of the muscular dystrophy phenotype.
Key Words: intracellular signaling skeletal muscle muscular dystrophy p70s6 kinase p38 ERK
This article has been cited by other articles:
![]() |
K. Hnia, J. Gayraud, G. Hugon, M. Ramonatxo, S. De La Porte, S. Matecki, and D. Mornet L-Arginine Decreases Inflammation and Modulates the Nuclear Factor-{kappa}B/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers Am. J. Pathol., June 1, 2008; 172(6): 1509 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Parsons, D. P. Millay, M. A. Sargent, F. J. Naya, E. M. McNally, H. L. Sweeney, and J. D. Molkentin Genetic Disruption of Calcineurin Improves Skeletal Muscle Pathology and Cardiac Disease in a Mouse Model of Limb-Girdle Muscular Dystrophy J. Biol. Chem., March 30, 2007; 282(13): 10068 - 10078. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hnia, G. Hugon, F. Rivier, A. Masmoudi, J. Mercier, and D. Mornet Modulation of p38 Mitogen-Activated Protein Kinase Cascade and Metalloproteinase Activity in Diaphragm Muscle in Response to Free Radical Scavenger Administration in Dystrophin-Deficient Mdx Mice Am. J. Pathol., February 1, 2007; 170(2): 633 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Judge, M. Haraguchiln, and J. S. Chamberlain Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex J. Cell Sci., April 15, 2006; 119(8): 1537 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Brazeau Understanding Cellular Signaling Pathways and Their Relationship to Genotype and Phenotype of Muscle Disease Experimental Biology and Medicine, May 1, 2005; 230(5): 289 - 290. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |